Reduction BACE1 expression via suppressing NF-κB mediated signaling by Tamibarotene in a mouse model of Alzheimer’s disease

Aimin Qiao(Guangdong Pharmaceutical University), Zizhuo Zhao(Sun Yat-sen University), Jieyi Li(Maastricht University), Jinquan Wang(Guangdong Pharmaceutical University), Yaohua Hu(Zhejiang A & F University)
IBRO Neuroscience Reports
February 16, 2021
10.1016/j.ibneur.2021.02.004
Cited by 26

Related Papers

Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan
|Breast Cancer Research and Treatment|1997|93
Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular–kidney–metabolic syndrome stages 0–3: a nationwide prospective cohort study
|Cardiovascular Diabetology|2025|50
Reduction of Torque Ripple and Rotor Eddy Current Losses by Closed Slots Design in a High-Speed PMSM for EHA Applications
|IEEE Transactions on Magnetics|2021|45
Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway
|Frontiers in Oncology|2020|38
Association Study of Tumor Necrosis Factor Receptor Type 2 M196R and Toll-Like Receptor 2 Arg753Gln Polymorphisms with Acne Vulgaris in a Chinese Han Ethnic Group
|Dermatology|2010|27